Stephen Frye, PhD, director for the Center for Integrative Chemical Biology & Drug Discovery, UNC Chapel Hill, Eshelman School of Pharmacy, will deliver the September DCI Seminar. Frye is also the lead principal investigator for the North Carolina Comprehensive Chemical Biology Center, a UNC-based, NCI designated center that engages in oncology drug discovery. His research focuses on chemical biology of chromatin regulation and drug discovery. Frye will deliver the lecture “Academic Drug Discovery and Chemical Biology,” from 8:10 a.m. to 9 a.m. on Wednesday, Sept. 30, in Room 143 of the Jones Building. Frye’s lecture will be preceded by a hematology-oncology fellow presentation starting at 7:30 a.m. All are invited to attend. For more information, contact Erin Carr.
Download DCI Seminar Series_9.30.15_Flyer